ETHNIC DISPARITIES IN LIVER TRANSPLANT PATIENTS WITH HEPATOCELLULAR CARCINOMA AND EXCEPTION POINTS APPROVED

被引：0
|
作者：
Goyes, Daniela [1 ]
Nsubuga, John P. [2 ]
Medina, Esli [1 ]
Patwardhan, Vilas [3 ]
Bonder, Alan [3 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Div Gastroenterol & Hepatol, Boston, MA 02215 USA
[2] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
[3] Beth Israel Deaconess Med Ctr, Dept Med, Div Gastroenterol, Boston, MA 02215 USA
来源：
HEPATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
645
引用
收藏
页码：389A / 390A
页数：2
相关论文
共 50 条
  • [41] Racial and ethnic disparities in psychosocial evaluation and liver transplant waitlisting
    Deutsch-Link, Sasha
    Bittermann, Therese
    Nephew, Lauren
    Ross-Driscoll, Katherine
    Weinberg, Ethan M.
    Weinrieb, Robert M.
    Olthoff, Kim M.
    Addis, Senayish
    Serper, Marina
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2023, 23 (06) : 776 - 785
  • [42] Racial/Ethnic Disparities in Survival of Patients Diagnosed With Localized Hepatocellular Carcinoma (HCC) in Post-MELD Exception Era Between 2004 and 2007 in the United States
    Devaki, Pardha
    Marupakula, Vidyasagargoud
    Nangia, Sharad
    Njei, Basile
    Ditah, Ivo C.
    Nguyen, Mindie H.
    [J]. GASTROENTEROLOGY, 2013, 144 (05) : S55 - S55
  • [43] Evaluating the validity of model for end-stage liver disease exception points for hepatocellular carcinoma patients with multiple nodules <2 cm
    Samoylova, Mariya L.
    Dodge, Jennifer L.
    Mehta, Neil
    Yao, Francis Y.
    Roberts, John P.
    [J]. CLINICAL TRANSPLANTATION, 2015, 29 (01) : 52 - 59
  • [44] Durvalumab and tremelimumab for hepatocellular carcinoma in patients listed for a liver transplant.
    Sohal, Davendra
    Moreland, Katie
    Quillin, Ralph
    Lemon, Kristina
    Rojan, Adam
    Olowokure, Olugbenga Olanrele
    Shah, Shimul
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : TPS638 - TPS638
  • [45] Hepatocellular carcinoma in advanced liver cirrhosis: CT detection in transplant patients
    Lim, JH
    Park, CK
    [J]. ABDOMINAL IMAGING, 2004, 29 (02): : 203 - 207
  • [46] Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma
    Park, Sang-Jae
    Freise, Chris E.
    Hirose, Ryutaro
    Kerlan, Robert K.
    Yao, Francis Y.
    Roberts, John P.
    Vagefi, Parsia A.
    [J]. CLINICAL TRANSPLANTATION, 2012, 26 (04) : E359 - E364
  • [47] An active liver transplant programme for hepatocellular carcinoma in cirrhotic patients: is it justified?
    Chui, AKK
    Rao, ARN
    McCaughan, GW
    Waugh, R
    Verran, DJ
    Koorey, D
    Painter, D
    Sheil, AGR
    [J]. CLINICAL TRANSPLANTATION, 1999, 13 (06) : 531 - 535
  • [48] Hepatocellular Carcinoma Patients Are Advantaged in the Current Liver Transplant Allocation System
    Washburn, K.
    Edwards, E.
    Harper, A.
    Freeman, R. B.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (07) : 1643 - 1648
  • [49] Treating Hepatocellular Carcinoma With Sorafenib in Liver Transplant Patients: An Initial Experience
    Saidi, R. F.
    Shah, S. A.
    Rawson, A. P.
    Grossman, St
    Piperdi, B.
    Bozorgzadeh, A.
    [J]. TRANSPLANTATION PROCEEDINGS, 2010, 42 (10) : 4582 - 4584
  • [50] Role of hepatocellular carcinoma therapy for patients in the waiting list for liver transplant
    Pascual, S.
    Irurzun, J.
    Miralles, C.
    Bernabe, J. M.
    Rodriguez, M.
    Bellot, P.
    Melgar, P.
    Alcazar, C.
    Lluis, F.
    Palazon, J. M.
    Rodriguz-Laiz, G.
    [J]. TRANSPLANTATION, 2021, 105 (08) : 130 - 130
12345